Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 19.
Article
Armstrong, CW;
Mensah, FFK;
Leandro, MJ;
Reddy, V;
Gooley, PR;
Berkovitz, S;
Cambridge, G;
(2024)
In vitro B cell experiments explore the role of CD24, CD38, and energy metabolism in ME/CFS.
Frontiers in Immunology
, 14
, Article 1178882. 10.3389/fimmu.2023.1178882.
|
Becerra, E;
De La Torre, I;
Leandro, MJ;
Cambridge, G;
(2017)
B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets.
Clinical and Experimental Immunology
, 190
(3)
pp. 372-383.
10.1111/cei.13024.
|
Cambridge, G;
Moura, RA;
Santos, T;
Khawaja, AA;
Polido-Pereira, J;
Canhão, H;
Leandro, MJ;
(2014)
Expression of the Inherently Autoreactive Idiotope 9G4 on Autoantibodies to Citrullinated Peptides and on Rheumatoid Factors in Patients with Early and Established Rheumatoid Arthritis.
PLoS One
, 9
(9)
, Article e107513 . 10.1371/journal.pone.0107513.
|
Christian, Sherri L;
Cambridge, Geraldine;
(2024)
Editorial: CD24 in the regulation of cellular development and disease.
Frontiers in Immunology
, 15
, Article 1374701. 10.3389/fimmu.2024.1374701.
|
Conrad, Nathalie;
Misra, Shivani;
Verbakel, Jan Y;
Verbeke, Geert;
Molenberghs, Geert;
Taylor, Peter N;
Mason, Justin;
... Cambridge, Geraldine; + view all
(2023)
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK.
The Lancet
, 401
(10391)
pp. 1878-1890.
10.1016/S0140-6736(23)00457-9.
|
Conrad, Nathalie;
Verbeke, Geert;
Molenberghs, Geert;
Goetschalckx, Laura;
Callender, Thomas;
Cambridge, Geraldine;
Mason, Justin C;
... Verbakel, Jan Y; + view all
(2022)
Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK.
The Lancet
, 400
(10354)
pp. 733-743.
10.1016/S0140-6736(22)01349-6.
|
Hennessey, A;
Lukawska, J;
Cambridge, G;
Isenberg, D;
Leandro, M;
(2019)
Adverse infusion reactions to rituximab in systemic lupus erythematosus: a retrospective analysis.
BMC Rheumatology
, 3
, Article 32. 10.1186/s41927-019-0082-7.
|
Lima, J;
Cambridge, G;
Vilas-Boas, A;
Martins, C;
Borrego, L-M;
Leandro, M;
(2019)
Serum markers of B-cell activation in pregnancy during late gestation, delivery, and the postpartum period.
American Journal of Reproductive Immunology
, 81
(3)
, Article e13090. 10.1111/aji.13090.
|
Martins, C;
Lima, J;
Cambridge, G;
Ângelo-Dias, M;
Leandro, M;
Miguel Borrego, L;
(2021)
Serum markers of B-cell activation in pregnant women with atopic asthma.
American Journal of Reproductive Immunology
, 86
(2)
, Article e13414. 10.1111/aji.13414.
|
Mensah, FFK;
Armstrong, CW;
Reddy, V;
Bansal, AS;
Berkovitz, S;
Leandro, MJ;
Cambridge, G;
(2018)
CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Frontiers in Immunology
, 9
, Article 242. 10.3389/fimmu.2018.02421.
|
Mensah, FKF;
Bansal, AS;
Ford, B;
Cambridge, G;
(2017)
Chronic fatigue syndrome and the immune system: Where are we now?
[Review].
Neurophysiologie Clinique/Clinical Neurophysiology
, 47
(2)
pp. 131-138.
10.1016/j.neucli.2017.02.002.
|
Norris-Grey, C;
Cambridge, G;
Moore, S;
Reddy, V;
Leandro, M;
(2022)
Long-term persistence of rituximab in patients with rheumatoid arthritis: an evaluation of the UCL cohort from 1998 to 2020.
Rheumatology
, 61
(2)
pp. 591-596.
10.1093/rheumatology/keab248.
|
Peckham, H;
Cambridge, G;
Bourke, L;
Sen, D;
Radziszewska, A;
Leandro, M;
Ioannou, Y;
(2017)
Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
Arthritis & Rheumatology
, 69
(7)
pp. 1387-1395.
10.1002/art.40117.
|
Reddy, VR;
Pepper, RJ;
Shah, K;
Cambridge, G;
Henderson, SR;
Klein, C;
Kell, L;
... Leandro, MJ; + view all
(2021)
Disparity in Peripheral and Renal B-cell Depletion with Rituximab in Systemic Lupus Erythematosus: an Opportunity for Obinutuzumab?
Rheumatology (Oxford)
, Article keab827. 10.1093/rheumatology/keab827.
(In press).
|
Reddy, V;
Cambridge, G;
Isenberg, DA;
Glennie, MJ;
Cragg, MS;
Leandro, M;
(2015)
Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus.
Arthritis & Rheumatology
, 67
(8)
pp. 2046-2055.
10.1002/art.39167.
|
Reddy, V;
Klein, C;
Isenberg, DA;
Glennie, MJ;
Cambridge, G;
Cragg, MS;
Leandro, MJ;
(2017)
Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples.
Rheumatology
, 56
(7)
pp. 1227-1237.
10.1093/rheumatology/kex067.
|
Reddy, V;
Martinez, L;
Isenberg, DA;
Leandro, MJ;
Cambridge, G;
(2016)
Pragmatic treatment of patients with Systemic Lupus Erythematosus with rituximab: Long-term effects on serum immunoglobulins.
Arthritis Care Res (Hoboken)
, 69
(6)
pp. 857-866.
10.1002/acr.22993.
|
Shin, Jin-Sup;
Subhan, Maryam;
Cambridge, Geraldine;
Guo, Yanping;
de Groot, Rens;
Scully, Marie;
Thomas, Mari;
(2022)
Alterations in B- and circulating T-follicular helper cell subsets in immune thrombotic thrombocytopenic purpura.
Blood Advances
, 6
(12)
pp. 3792-3802.
10.1182/bloodadvances.2022007025.
|
|
Stopforth, RJ;
Oldham, RJ;
Tutt, AL;
Duriez, P;
Chan, HTC;
Binkowski, BF;
Zimprich, C;
... Cragg, MS; + view all
(2018)
Detection of Experimental and Clinical Immune Complexes by Measuring SHIP-1 Recruitment to the Inhibitory FcγRIIB.
The Journal of Immunology
, 200
(5)
pp. 1937-1950.
10.4049/jimmunol.1700832.
|